Robert J. Mulroy
Fondateur chez Partner Therapeutics, Inc.
Postes actifs de Robert J. Mulroy
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Partner Therapeutics, Inc.
 Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - | |
| Fondateur | - | - |
Historique de carrière de Robert J. Mulroy
Anciens postes connus de Robert J. Mulroy
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 27/01/2011 | 03/10/2016 |
| Directeur Général | 01/05/1999 | 03/10/2016 | |
| President | 01/05/1999 | 03/10/2016 |
Formation de Robert J. Mulroy
| Stanford University | Undergraduate Degree |
| Yale University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| President | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Partner Therapeutics, Inc.
Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Robert J. Mulroy
- Expérience
